Unternehmen Applied Genetic Technologies Corporation
Aktien
A110V2
US03820J1007
AGTC
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 102
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 01.11.22 |
David Jacobs
CTO | Chief Tech/Sci/R&D Officer | - | 08.06.22 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 47 | 01.12.22 |
Abraham Scaria
CTO | Chief Tech/Sci/R&D Officer | - | 15.11.21 |
Ashwin Datt
BRD | Director/Board Member | - | 01.12.22 |
Chris Hollowood
BRD | Director/Board Member | 50 | 01.12.22 |
Hope D'Oyley-Gay
LAW | General Counsel | - | 11.11.21 |
Gerald Reynolds
TRE | Treasurer | - | 01.03.20 |
Janet Rae
LAW | General Counsel | - | 18.06.21 |
Matthew Feinsod
PRN | Corporate Officer/Principal | - | 01.07.14 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 01.11.22 |
Chris Hollowood
BRD | Director/Board Member | 50 | 01.12.22 |
Ashwin Datt
BRD | Director/Board Member | - | 01.12.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 67 686 195 | 67 316 723 ( 99,45 %) | 54 000 ( 0,0798 %) | 99,45 % |
Unternehmenskontakt
Beacon Therapeutics (USA), Inc.
14193 NW 119th Terrace Suite 10
32615, Alachua
+386 462 2204
http://agtc.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+8.96% | 105 Mrd. | |
-1.43% | 104 Mrd. | |
+4.40% | 22.94 Mrd. | |
-12.15% | 22.34 Mrd. | |
-4.36% | 19.25 Mrd. | |
-39.98% | 17.08 Mrd. | |
-10.04% | 16.96 Mrd. | |
+6.79% | 14.16 Mrd. | |
+38.61% | 12.63 Mrd. |